Literature DB >> 2602149

Synthesis and evaluation of some novel phosphate and phosphinate derivatives of araA. Studies on the mechanism of action of phosphate triesters.

C McGuigan1, J M Shackleton, S M Tollerfield, P A Riley.   

Abstract

A number of novel phosphinate and phosphate triester derivatives of the anti-viral nucleoside analogue araA have been prepared. Spectroscopic and analytical data have been collected on both the reagents and the nucleotides. An in vitro assay indicated inhibition of DNA synthesis by mammalian cells, by each of the nucleotide derivatives, in the range 3-30 microM. Inhibition was reduced, but not abolished, for the phosphinates relative to the phosphates. These results are consistent with a mode of action involving release of the free nucleoside araA and the nucleotide araAMP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2602149      PMCID: PMC335291          DOI: 10.1093/nar/17.24.10171

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  15 in total

1.  Synthesis and biological evaluation of some phosphate triester derivatives of the anti-viral drug AraA.

Authors:  C McGuigan; S M Tollerfield; P A Riley
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

2.  Bis(m-nitrophenyl) and bis(p-nitrophenyl) esters and the phosphorodiamidate of thymidine 5'-phosphate as potential sources of intracellular thymidine 5'-phosphate in mouse cells in culture.

Authors:  R R Chawla; J J Freed; A Hampton
Journal:  J Med Chem       Date:  1984-12       Impact factor: 7.446

3.  In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.

Authors:  Y J Bryson; J D Connor
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

4.  Rational development of a soluble prodrug of a cytotoxic nucleoside: preparation and properties of arabinosyladenine 5'-formate.

Authors:  A J Repta; B J Rawson; R D Shaffer; K B Sloan; N Bodor; T Higuchi
Journal:  J Pharm Sci       Date:  1975-03       Impact factor: 3.534

5.  Synthesis and biological properties of some cyclic phosphotriesters derived from 2'-deoxy-5-fluorouridine.

Authors:  R N Hunston; A S Jones; C McGuigan; R T Walker; J Balzarini; E De Clercq
Journal:  J Med Chem       Date:  1984-04       Impact factor: 7.446

6.  The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).

Authors:  F M Schabel
Journal:  Chemotherapia (Basel)       Date:  1968

7.  Synthesis and biological evaluation of 9-[5'-(2-oxo-1,3,2-oxazaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine and 9-[5'-(2-oxo-1,3,2-dioxaphosphorinan-2-yl)-beta-D-arabinosyl]ade nine: potential neutral precursors of 9-[beta-D-arabinofuranosyl]adenine 5'-monophosphate.

Authors:  D Farquhar; R Smith
Journal:  J Med Chem       Date:  1985-09       Impact factor: 7.446

8.  Synthesis and biological evaluation of neutral derivatives of 5-fluoro-2'-deoxyuridine 5'-phosphate.

Authors:  D Farquhar; N J Kuttesch; M G Wilkerson; T Winkler
Journal:  J Med Chem       Date:  1983-08       Impact factor: 7.446

9.  Human leukemic cells resistant to 5-fluoro-2'-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides.

Authors:  A R Bapat; C Zarow; P V Danenberg
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

10.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  6 in total

1.  Thiophene-expanded guanosine analogues of Gemcitabine.

Authors:  Zhe Chen; Therese C Ku; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem Lett       Date:  2015-07-30       Impact factor: 2.823

Review 2.  Antiviral lead compounds from marine sponges.

Authors:  Sunil Sagar; Mandeep Kaur; Kenneth P Minneman
Journal:  Mar Drugs       Date:  2010-10-11       Impact factor: 5.118

Review 3.  Improving nucleoside analogs via lipid conjugation: Is fatter any better?

Authors:  Peter Alexander; Gregory Kucera; Timothy S Pardee
Journal:  Crit Rev Oncol Hematol       Date:  2016-01-21       Impact factor: 6.312

4.  Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031.

Authors:  Awa Sarr; Jennifer Bré; In Hwa Um; Tsz Huen Chan; Peter Mullen; David J Harrison; Paul A Reynolds
Journal:  Sci Rep       Date:  2019-05-21       Impact factor: 4.379

Review 5.  The ProTide Prodrug Technology: From the Concept to the Clinic.

Authors:  Youcef Mehellou; Hardeep S Rattan; Jan Balzarini
Journal:  J Med Chem       Date:  2017-08-24       Impact factor: 7.446

6.  Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study.

Authors:  Sarah P Blagden; Ivana Rizzuto; Puvan Suppiah; Daniel O'Shea; Markand Patel; Laura Spiers; Ajithkumar Sukumaran; Nishat Bharwani; Andrea Rockall; Hani Gabra; Mona El-Bahrawy; Harpreet Wasan; Robert Leonard; Nagy Habib; Essam Ghazaly
Journal:  Br J Cancer       Date:  2018-09-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.